ALT
Altimmune, Inc.
Altimmune, Inc. (ALT) has 10 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 3, 2026.
Insiders have net bought $198K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Jerome Benedict Durso
- Employees:59
- HQ:Gaithersburg, MD, US
- IPO:2017-05-26
Insider Buying
$198K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$585.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
GILL JOHNFirst filing | Director | Purchase | 9,200 | $31K | Apr 6 | SEC ↗ |
| Chief Financial Officer | Purchase | 10,000 | $31K | Apr 1 | SEC ↗ | |
| President and CEO | Purchase | 15,000 | $47K | Apr 1 | SEC ↗ | |
Durso Jerome BenedictFirst filing | President and CEO | Purchase | 20,000 | $71K | Mar 9 | SEC ↗ |
WEAVER GREGORY LFirst filing | Chief Financial Officer | Purchase | 5,000 | $18K | Mar 9 | SEC ↗ |
Related companies
Altimmune, Inc. is in the Healthcare sector.